{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:59:42Z","timestamp":1772413182644,"version":"3.50.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.jacl.2024.10.005","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T20:48:07Z","timestamp":1731530887000},"page":"134-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7041-9075","authenticated-orcid":false,"given":"Antoinette S.","family":"Birs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-9338","authenticated-orcid":false,"given":"Andrew S.","family":"Kao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5605-0646","authenticated-orcid":false,"given":"Elizabeth","family":"Silver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pam R.","family":"Taub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3800-7369","authenticated-orcid":false,"given":"Michael J.","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2024.10.005_bib0001","article-title":"Non-HDL cholesterol and residual risk of cardiovascular events in patients with ischemic heart disease and well-controlled LDL cholesterol: a cohort study","volume":"36","author":"Hansen","year":"2024","journal-title":"Lancet Reg Health - Europe"},{"key":"10.1016\/j.jacl.2024.10.005_bib0002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.2165\/00002018-199716040-00002","article-title":"Post-transplant diabetes mellitus. The role of immunosuppression","volume":"16","author":"Jindal","year":"1997","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacl.2024.10.005_bib0003","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11113247","article-title":"Proprotein convertase subtilisin\/kexin type 9 inhibitors use for atherogenic dyslipidemia in solid organ transplant patients","volume":"11","author":"Cuomo","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.jacl.2024.10.005_bib0004","article-title":"Impact of statin use after heart transplantation","volume":"9","author":"Vallakati","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.10.005_bib0005","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.healun.2004.08.014","article-title":"Survival, graft atherosclerosis, and rejection incidence in heart transplant recipients treated with statins: 5-year follow-up","volume":"24","author":"Stojanovic","year":"2005","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0006","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","article-title":"Effect of pravastatin on outcomes after cardiac transplantation","volume":"333","author":"Kobashigawa","year":"1995","journal-title":"New Eng J Med"},{"key":"10.1016\/j.jacl.2024.10.005_bib0007","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.CIR.0000151805.86933.35","article-title":"Drug therapy in the heart transplant recipient: part IV: drug-drug interactions","volume":"111","author":"Page","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.10.005_bib0008","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1161\/CIRCULATIONAHA.111.040360","article-title":"Sirolimus as primary immunosuppression attenuates allograft vasculopathy with improved late survival and decreased cardiac events after cardiac transplantation","volume":"125","author":"Topilsky","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.10.005_bib0009","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.healun.2021.07.015","article-title":"The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-eighth adult heart transplantation report - 2021; Focus on recipient characteristics","volume":"40","author":"Khush","year":"2021","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/S1053-2498(02)00492-8","article-title":"Is all intimal proliferation created equal in cardiac allograft vasculopathy? The quantity\u2013quality paradox","volume":"22","author":"Mehra","year":"2003","journal-title":"J Heart Lung Tranplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0035","doi-asserted-by":"crossref","unstructured":"St. Goar FG, et al. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of \"angiographically silent\" intimal thickening. Circulation. 1992;85(3):979-987.","DOI":"10.1161\/01.CIR.85.3.979"},{"key":"10.1016\/j.jacl.2024.10.005_bib0036","doi-asserted-by":"crossref","unstructured":"Mehra MR, et al. International Society for Heart and Lung Transplantation working formulating of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transplant. 2010;29(7):717-727","DOI":"10.1016\/j.healun.2010.05.017"},{"key":"10.1016\/j.jacl.2024.10.005_bib0011","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; focus theme: primary diagnostic indications for transplant","volume":"35","author":"Lund","year":"2016","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0012","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1600-6143.2009.02949.x","article-title":"Predicting coronary heart disease after kidney transplantation: Patient Outcomes in Renal Transplantation (PORT) Study","volume":"10","author":"Israni","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0013","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/j.1600-6143.2012.04077.x","article-title":"Diabetes, hypertension and hyperlipidemia: prevalence over time and impact on long-term survival after liver transplantation","volume":"12","author":"Parekh","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0014","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1016\/j.jacc.2020.10.008","article-title":"Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease","volume":"76","author":"Olga","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.10.005_bib0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.111.081059","article-title":"Statins and the risk of cancer after heart transplantation","volume":"126","author":"Frohlich","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.10.005_bib0016","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0002-9149(03)00456-9","article-title":"Effect of atorvastatin on postcardiac transplant increase in low-density lipoprotein cholesterol reduces development of intimal hyperplasia and progression of endothelial dysfunction","volume":"92","author":"See","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2024.10.005_bib0017","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1161\/CIRCULATIONAHA.107.711911","article-title":"Cardiac allograft vasculopathy: recent developments","volume":"117","author":"Schmauss","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.10.005_bib0018","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1053-2498(00)00128-5","article-title":"Role of statins in the management of dyslipidemia after cardiac transplant: randomized controlled trial comparing the efficacy and the safety of atorvastatin with pravastatin","volume":"19","author":"Magnani","year":"2000","journal-title":"J Heart Lung Tranplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0019","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.healun.2005.02.009","article-title":"Ten-year follow-up of a randomized trial of pravastatin in heart transplant patients","volume":"24","author":"Kobashigawa","year":"2005","journal-title":"J Heart Lung Tranplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0020","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jacc.2017.12.005","article-title":"Long-term sirolimus for primary immunosuppression in heart transplant recipients","volume":"71","author":"Asleh","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.10.005_bib0021","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1111\/ajt.12208","article-title":"Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice","volume":"13","author":"Masetti","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0022","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJM198801073180110","article-title":"Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin","volume":"318","author":"Norman","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2024.10.005_bib0023","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacl.2024.10.005_bib0024","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1161\/CIR.0000000000000456","article-title":"Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association","volume":"134","author":"Wiggins","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.10.005_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/106002809502900301","article-title":"Efficacy and pharmacokinetics of simvastatin in heart transplant recipients","volume":"29","author":"Campana","year":"1995","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jacl.2024.10.005_bib0026","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/107424840100600404","article-title":"Pharmacokinetics and pharmacodynamics of fluvastatin in heart transplant recipients taking cyclosporine A","volume":"6","author":"Park","year":"2001","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.jacl.2024.10.005_bib0027","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0021-9150(01)00438-5","article-title":"Changes in lipid metabolism and effect of simvastatin in renal transplant recipients induced by cyclosporine or tacrolimus","volume":"158","author":"Ichimaru","year":"2001","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacl.2024.10.005_bib0028","article-title":"Randomized trial of cholesterol lowering with evolocumab for cardiac allograft vasculopathy in heart transplant recipients","author":"Broch","year":"2024","journal-title":"J Am Coll Cardiol HF"},{"key":"10.1016\/j.jacl.2024.10.005_bib0029","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15294","article-title":"Cardiac allograft vasculopathy in heart transplant recipients from hepatitis C viremic donors","volume":"38","author":"Kadosh","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jacl.2024.10.005_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhlto.2024.100065","article-title":"Cardiac allograft vasculopathy outcomes among donation after circulatory death heart transplant recipients","volume":"4","author":"Birs","year":"2024","journal-title":"JHLT Open"},{"key":"10.1016\/j.jacl.2024.10.005_bib0031","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.cardfail.2020.12.012","article-title":"Influence of donor transmitted and rapidly progressive coronary vascular disease on long-term outcomes after heart transplantation: a contemporary intravascular ultrasound analysis","volume":"27","author":"Sperry","year":"2021","journal-title":"J Card Fail"},{"key":"10.1016\/j.jacl.2024.10.005_bib0032","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1097\/TP.0000000000001322","article-title":"Donor-transmitted atherosclerosis associated with worsening cardiac allograft vasculopathy after heart transplantation: serial volumetric intravascular ultrasound analysis","volume":"101","author":"Watanabe","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.jacl.2024.10.005_bib0033","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.jacc.2023.06.016","article-title":"Prevalence, characteristics, and prognostic relevance of donor-transmitted coronary artery disease in heart transplant recipients","volume":"82","author":"Couto-Mall\u00f3n","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.10.005_bib0034","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.healun.2007.07.001","article-title":"Coronary plaque classification using intravascular ultrasound\u2014radiofrequency analysis in a heart transplant patient with severe atherosclerosis","volume":"26","author":"K\u00f6nig","year":"2007","journal-title":"J Heart Lung Transplantat"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002630?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002630?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T09:53:47Z","timestamp":1741686827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424002630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1933287424002630"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.10.005","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden of atherogenic lipids and association with cardiac allograft vasculopathy in heart transplant recipients","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}